Skip to content

Outcome of multimodal periarticular injection with corticosteroid for better pain management in total knee arthroplasty: A randomized controlled trial

Outcome of multimodal periarticular injection with corticosteroid for better pain management in total knee arthroplasty: A randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20211216004
Enrollment
22
Registered
2021-12-16
Start date
2019-05-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-operative pain after total knee arthroplasty Pain VAS TKA Steroid Periarticular injection

Interventions

Periarticular injection contain triamcinolone 40 mg 0.5% Bupivacaine 50 mg Ketorolac 30 mg and NSS 9 ml,Periarticular injection contain 0.5% Bupivacaine 50 mg Ketorolac 30 mg and NSS 9 ml
Experimental Procedure/Surgery,Experimental Procedure/Surgery
Corticosteroid group,Control group

Sponsors

none
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: patient age 40 - 80 years diagnosed with OA knee and eligible for unilateral primary total knee arthroplasty

Exclusion criteria

Exclusion criteria: Poor controlled DM HbA1C > 8 ESRD Other inflammatory arthritis Immunocompromised host Allergic to drug in trial

Design outcomes

Primary

MeasureTime frame
Pain score post-operative day 1,2 and 3 VAS

Secondary

MeasureTime frame
Time to straight leg raise, post-operatively post-operative day 1,2 and 3 hour,Time to ambulation, post-operatively post-operative day 1,2 and 3 hour,Adverse outcome of corticosteroid injection 1 month visit percentage of infection or tendon rupture

Countries

Thailand

Contacts

Public ContactNatthicha Saowatanpong

Police general hospital

aeinatsao@gmail.com022076000

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026